Most Viewed Post
Cardiovascular Drug Development Surges with Innovative Therapies and Fierce Market Competition.
The cardiovascular disease treatment landscape is entering a transformative era with ...
CTI’s Global Rise: Advancing Clinical Research from Cincinnati to the World
From its Cincinnati origins, CTI Clinical Trial & Consulting has grown into a global ...
Verve’s VERVE-102 Shows Strong Safety and Efficacy, Positions Lilly for Key 2025 Decision
Verve Therapeutics has reported encouraging early-phase results for VERVE-102, its ne...
Tempest Therapeutics Seeks Strategic Partners as Funding Dries Up for Liver Cancer Drug
Facing harsh financial headwinds, Tempest Therapeutics is actively pursuing strategic...
Ironwood Faces Setback as FDA Requires New Phase 3 Trial for GI Drug Apraglutide
Ironwood Pharmaceuticals must conduct another Phase 3 trial for apraglutide after the...
Synthetic Suppressor T Cells Offer Precision Immunosuppression Without Systemic Risks
Researchers have engineered synthetic T cells to locally suppress immune responses, p...
Scientists Call for a Ban on Mirror Bacteria Research Over Safety Concerns
A group of leading synthetic biologists urges a halt to mirror bacteria research due ...
Anthrobots: Human-Cell Robots That Build Bridges and Heal
In a groundbreaking study, researchers have developed “anthrobots” — living robots ma...
Please Accept Cookies for Better Performance